Joseph Han, MD
Otolaryngology · Norfolk, VANPI 1760577985
Payments from drug & device makers
Across 1,822 payments — averaging $1567.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$668K
- Optinose US, Inc.$528K
- Sanofi$382K
- AstraZeneca$338K
- Regeneron Healthcare Solutions, Inc.$282K
- Sanofi US Services Inc.$144K
- plus $515K from 28 others
Across 130 payments — averaging $499.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$19K
- Sanofi-aventis U.S. LLC$17K
- F. Hoffmann-la Roche AG$16K
- Regeneron$5K
- Sanofi US Services Inc.$4K
- GSK$3K
- plus $1K from 1 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 336 | $668,384 |
| Optinose US, Inc. | 367 | $527,971 |
| Sanofi | 184 | $381,794 |
| AstraZeneca | 154 | $337,721 |
| Regeneron Healthcare Solutions, Inc. | 222 | $281,782 |
| Sanofi US Services Inc. | 20 | $143,585 |
| Medtronic(2 entities) | 148 | $108,628 |
| Aerin Medical Inc. | 62 | $89,332 |
| Regeneron | 92 | $73,783 |
| Roche Products Limited | 19 | $62,939 |
| Insmed, Inc. | 20 | $50,930 |
| Astrazeneca UK Limited | 29 | $34,082 |
| Alk-abello, Inc | 31 | $21,255 |
| Intersect ENT, Inc. | 42 | $12,571 |
| Sanofi-aventis U.S. LLC | 5 | $12,164 |
| Merck | 14 | $11,504 |
| Genentech, Inc. | 16 | $9,080 |
| F. Hoffmann-la Roche AG | 13 | $8,222 |
| Stryker | 7 | $6,864 |
| Novartis | 7 | $4,872 |
| Paratek Pharmaceuticals, Inc. | 4 | $3,693 |
| Astrazeneca AB | 1 | $2,417 |
| Pfizer | 1 | $1,110 |
| Acclarent, Inc | 7 | $435 |
| Phadia US Inc. | 4 | $375 |
| Integra Lifesciences Corporation | 3 | $299 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $256 |
| Genentech USA, Inc. | 5 | $222 |
| Grifols USA, LLC | 1 | $128 |
| Amgen | 1 | $80 |
| KARL Storz Endoscopy-america | 2 | $78 |
| Acera Surgical, Inc. | 1 | $40 |
| Johnson & Johnson | 1 | $24 |
| CSL Behring | 1 | $20 |
How this compares
$2,856,637 in reported general payments places this provider in the 95th percentile of 241 otolaryngology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngology in Norfolk
- Kent LamNorfolk$143K
- Craig DerkayNorfolk$33K
- David DarrowNorfolk$12K
- Cristina BaldassariNorfolk$8K
- Laurence OhalloranAnnandale$2.9M
- Ryan NordRichmond$482K
- Paul LenkowskiRoanoke$282K
- Nipun ChhabraLeesburg$178K
- Charles GrossCharlottesville$91K
- Spencer PayneCharlottesville$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.